What’s on your Spring #CTBucketList?

Head of Hartford Healthcare Cancer Institute looks to increase participation in clinical trials

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

HARTFORD -- Dr. Peter Paul Yu has wanted to be a doctor since he was six-years-old, and now he is bringing that dedication to medicine to Connecticut.

He is the first physician-in-chief of the Hartford Healthcare Cancer Institute, which was recently recognized as a top oncology program by Becker's Hospital Review.

In this Healthier Connections report, brought to you by Hartford HealthCare, Sarah Cody introduces us to the former president of the American Society of Clinical Oncology, who believes we are poised to make tremendous strides in the fight against cancer.

New treatments are often the result of vitally important clinical trials.

Yet, according to a recent survey, only 4% of people with cancer in the U.S participate in these trials, a fact that Yu wants to change.

“It allows us to advance what we`re doing so that a year from now, 5 years from now we`ll be doing something better… clinical trials are the key to that.”

He hopes to debunk myths and show patients that clinical trials are safe and could help ensure their future.

Hartford Healthcare is partnering with memorial Sloan Kettering Cancer Center to achieve this goal.

This accomplished cancer expert is excited to work with the institute`s doctors and nurses to provide cancer patients with the best care possible.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.